Posted on March 17, 20213/17/21
Change Is Happening in the EU: What Pharma Companies Need to Know About the European Union’s New Pharmaceutical Strategy
Posted on March 3, 20213/3/21
Global Shifts in Legislative Regulation Are Forcing Pharma Back to the Drawing Board : February 2021
Posted on February 24, 20212/24/21
BLOG: Population Health Leadership
Posted on February 17, 20212/17/21
The Crush: How Covid-19 Is Impacting Mature Brand Revenue & Long-Term Value
Posted on February 11, 20212/11/21
Alternative Product Distribution Model: Where Agility Meets Profitability
Posted on February 7, 20212/7/21
A Time for Transition in Pharma: January 2021
Posted on February 5, 20212/5/21
Drug Pricing And Drug Price Reporting Regulatory Update
Posted on February 4, 20212/4/21
A Paul Simms Favorite: EVERSANA makes the list for 2021 Predictions
Posted on January 19, 20211/19/21
Moving Forward in Pharma: Reigniting Revenue for Mature Brands
Posted on January 18, 20211/18/21